Morgan Stanley
SLSN

Morgan Stanley’s Solesence Inc SLSN Stock Holding History

Morgan Stanley’s Portfolio SLSN Stock Details SLSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$139K Sell
188,797
-5,985
-3% -$7.39K ﹤0.01% 6116
2026
Q1 		$185K Buy
194,782
+159,494
+452% +$202K ﹤0.01% 5908
2025
Q4 		$56.3K Buy
35,288
+19,497
+123% +$52.8K ﹤0.01% 6396
2025
Q3 		$50.8K Sell
15,791
-17,033
-52% -$61K ﹤0.01% 6390
2025
Q2 		$143K Buy
+32,824
New +$115K ﹤0.01% 5987

Other funds holding SLSN

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DCM
Donaldson Capital Management Evansville, Indiana $3.5B AUM 28.74% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley's SLSN Position: Q2 2026 in Review

Morgan Stanley reduced its Solesence Inc (SLSN) stake by 3.1% in Q2 2026, selling an estimated $7.39K and leaving 188,797 shares worth $139K. The position accounts for ﹤0.01% of the portfolio, ranked #6116.

Morgan Stanley first reported a position in SLSN in Q2 2025 and has held it in 5 quarters since. The position peaked at $185K in Q1 2026. 44 funds tracked by Wall St. Rank hold SLSN as of Q2 2026.

  • Morgan Stanley held 188,797 shares of Solesence Inc worth $139K as of Q2 2026.
  • Morgan Stanley sold 5,985 Solesence Inc shares in Q2 2026, an estimated $7.39K.
  • Solesence Inc made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6116 holding.
  • Morgan Stanley first reported a position in Solesence Inc in Q2 2025 and has held it in 5 quarters since.
  • Morgan Stanley's Solesence Inc position peaked at $185K in Q1 2026.
  • 44 funds tracked by Wall St. Rank held Solesence Inc as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.